ACTI — Active Biotech AB publ Cashflow Statement
0.000.00%
Last trade - 00:00- SEK113.48m
- SEK48.48m
Annual cashflow statement for Active Biotech AB publ, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -49.8 | -58.4 | -45.8 | -39.4 | -37.3 |
| Depreciation | |||||
| Non-Cash Items | 1.56 | 2.19 | 1.85 | 0.013 | 1.6 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.1 | 1.34 | -1.79 | -2.67 | 3.3 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -46.2 | -54.9 | -45.7 | -40.4 | -32.4 |
| Capital Expenditures | — | -0.245 | 0 | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | — | -0.245 | 0 | — | — |
| Financing Cash Flow Items | -2.15 | -1.31 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 73.1 | 43.8 | 40.2 | 31.6 | 70.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 26.9 | -11.3 | -5.58 | -8.82 | 37.7 |